Last reviewed · How we verify
Drug: Tagitanlimab Drug: Capecitabine
Drug: Tagitanlimab Drug: Capecitabine is a Small molecule drug developed by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | Drug: Tagitanlimab Drug: Capecitabine |
|---|---|
| Sponsor | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Drug: Tagitanlimab Drug: Capecitabine CI brief — competitive landscape report
- Drug: Tagitanlimab Drug: Capecitabine updates RSS · CI watch RSS
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about Drug: Tagitanlimab Drug: Capecitabine
What is Drug: Tagitanlimab Drug: Capecitabine?
Drug: Tagitanlimab Drug: Capecitabine is a Small molecule drug developed by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd..
Who makes Drug: Tagitanlimab Drug: Capecitabine?
Drug: Tagitanlimab Drug: Capecitabine is developed by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (see full Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. pipeline at /company/sichuan-kelun-biotech-biopharmaceutical-co-ltd).
What development phase is Drug: Tagitanlimab Drug: Capecitabine in?
Drug: Tagitanlimab Drug: Capecitabine is in Phase 1.